Does NIVOLUMAB Cause Myopathy? 101 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Myopathy have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.
101
Reports of Myopathy with NIVOLUMAB
0.1%
of all NIVOLUMAB reports
19
Deaths
50
Hospitalizations
How Dangerous Is Myopathy From NIVOLUMAB?
Of the 101 reports, 19 (18.8%) resulted in death, 50 (49.5%) required hospitalization, and 6 (5.9%) were considered life-threatening.
Is Myopathy Listed in the Official Label?
Yes, Myopathy is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Myopathy?
ATORVASTATIN (1,243)
SIMVASTATIN (624)
ROSUVASTATIN (596)
PREDNISONE (526)
METHYLPREDNISOLONE (321)
PREDNISOLONE (246)
DEXAMETHASONE (203)
METFORMIN (197)
METHOTREXATE (196)
MYCOPHENOLATE MOFETIL (177)
Which NIVOLUMAB Alternatives Have Lower Myopathy Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE